Your browser doesn't support javascript.
loading
BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension.
Spikes, Leslie A; Bajwa, Abubakr A; Burger, Charles D; Desai, Sapna V; Eggert, Michael S; El-Kersh, Karim A; Fisher, Micah R; Johri, Shilpa; Joly, Joanna M; Mehta, Jinesh; Palevsky, Harold I; Ramani, Gautam V; Restrepo-Jaramillo, Ricardo; Sahay, Sandeep; Shah, Trushil G; Deng, Chunqin; Miceli, Melissa; Smith, Peter; Shapiro, Shelley M.
Afiliación
  • Spikes LA; Pulmonary and Critical Care Medicine University of Kansas Medical Center Kansas City Kansas USA.
  • Bajwa AA; Pulmonary Medicine Ascension St. Vincent's Hospital Southside Jacksonville Florida USA.
  • Burger CD; Pulmonary Medicine Mayo Clinic Jacksonville Florida USA.
  • Desai SV; Heart Failure and Transplantation Cardiology Ochsner Medical Center New Orleans Louisiana USA.
  • Eggert MS; Pulmonary and Critical Care Medicine Sentara Heart Hospital Norfolk Virginia USA.
  • El-Kersh KA; Pulmonary and Critical Care Medicine University of Nebraska Medical Center Omaha Nebraska USA.
  • Fisher MR; Pulmonary and Critical Care Medicine Emory University School of Medicine Atlanta Georgia USA.
  • Johri S; Pulmonary and Critical Care Medicine Henrico Doctors' Hospital and Bon Secours St. Francis Medical Center Richmond Virginia USA.
  • Joly JM; Cardiology, Heart Failure and Transplantation Cardiology University of Alabama at Birmingham Birmingham Alabama USA.
  • Mehta J; Pulmonary and Critical Care Medicine The Cleveland Clinic Weston Florida USA.
  • Palevsky HI; Pulmonary Medicine University of Pennsylvania Philadelphia Pennsylvania USA.
  • Ramani GV; Cardiology University of Maryland School of Medicine Baltimore Maryland USA.
  • Restrepo-Jaramillo R; Pulmonology and Critical Care Medicine University of South Florida College of Medicine Tampa Florida USA.
  • Sahay S; Pulmonary Hypertension and Pulmonary Critical Care Houston Methodist Hospital Houston Texas USA.
  • Shah TG; Pulmonary and Critical Care Medicine University of Texas Southwestern Medical Center Dallas Texas USA.
  • Deng C; Clinical Product Development United Therapeutics Corporation Research Triangle Park North Carolina USA.
  • Miceli M; Global Medical Affairs United Therapeutics Corporation North Carolina Research Triangle Park USA.
  • Smith P; Clinical Product Development United Therapeutics Corporation Research Triangle Park North Carolina USA.
  • Shapiro SM; Pulmonology, Greater Los Angeles VA Healthcare System Cardiology Section, and David Geffen UCLA School of Medicine Los Angeles California USA.
Pulm Circ ; 12(2): e12063, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35514770

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Pulm Circ Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Pulm Circ Año: 2022 Tipo del documento: Article